WCN26-7190 Lysyl-tRNA synthetase 1 (KARS1) promotes macrophage-mediated inflammation & fibrosis in chronic kidney disease

Read full text Summarise with VIRAT
Authors: Su Bin Lee, Seung Seob Son, Seong Woo Lee, Se Hun Park, J. S. Lee, Eun Young Lee
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Lysyl-tRNA synthetase 1 (KARS1) is an enzyme that catalyzes the attachment of lysine to tRNA during protein synthesis. Recent studies have suggested a non-canonical role for KARS1 as a signaling molecule that activates monocytes and macrophages and regulates their migration. Although KARS1 is known to be associated with inflammation and fibrosis in liver diseases, its role in chronic kidney disease (CKD) remains unclear. CKD is characterized by persistent macrophage infiltration, chronic inflammation, and fibrosis, ultimately leading to renal dysfunction.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Dialysis and Renal Disease Management Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104517–104517
Publication date
25 March 2026
Language
EN